Dimensional Fund Advisors LP Has $226.62 Million Position in Tenet Healthcare Corporation $THC

Dimensional Fund Advisors LP cut its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 5.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,200,882 shares of the company’s stock after selling 74,897 shares during the period. Dimensional Fund Advisors LP’s holdings in Tenet Healthcare were worth $226,624,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of THC. Price T Rowe Associates Inc. MD increased its position in Tenet Healthcare by 1.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,490,350 shares of the company’s stock worth $1,488,484,000 after buying an additional 119,809 shares during the last quarter. Boston Partners lifted its position in shares of Tenet Healthcare by 15.7% in the fourth quarter. Boston Partners now owns 3,642,136 shares of the company’s stock valued at $723,804,000 after buying an additional 494,581 shares during the last quarter. AQR Capital Management LLC increased its holdings in shares of Tenet Healthcare by 20.3% during the 4th quarter. AQR Capital Management LLC now owns 2,256,539 shares of the company’s stock worth $448,419,000 after acquiring an additional 380,116 shares during the last quarter. Ameriprise Financial Inc. raised its stake in Tenet Healthcare by 8.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock valued at $373,020,000 after acquiring an additional 157,109 shares during the period. Finally, Norges Bank acquired a new stake in Tenet Healthcare during the 4th quarter valued at $248,494,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Tenet Healthcare Trading Up 2.3%

Shares of Tenet Healthcare stock opened at $199.85 on Friday. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36. The firm has a 50-day moving average of $184.43 and a 200-day moving average of $197.37. Tenet Healthcare Corporation has a 52-week low of $146.60 and a 52-week high of $247.21. The stock has a market cap of $17.22 billion, a PE ratio of 10.39, a PEG ratio of 1.62 and a beta of 1.27.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Friday, July 24th. The company reported $6.12 earnings per share for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business had revenue of $5.63 billion during the quarter, compared to analysts’ expectations of $5.43 billion. During the same quarter in the previous year, the company earned $4.02 EPS. The business’s revenue was up 6.8% on a year-over-year basis. As a group, sell-side analysts forecast that Tenet Healthcare Corporation will post 17.5 EPS for the current year.

Insider Buying and Selling

In related news, Director Nadja West sold 3,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the sale, the director directly owned 24,805 shares in the company, valued at approximately $4,399,166.75. The trade was a 10.79% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director J Robert Kerrey sold 5,638 shares of the firm’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the transaction, the director owned 16,804 shares in the company, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.97% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities analysts have commented on THC shares. TD Cowen decreased their price objective on shares of Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Stephens reduced their target price on shares of Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating for the company in a report on Monday, May 4th. Guggenheim decreased their price target on shares of Tenet Healthcare from $252.00 to $242.00 and set a “buy” rating on the stock in a research note on Monday. Barclays raised their price objective on shares of Tenet Healthcare from $238.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 8th. Finally, Weiss Ratings cut Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 2nd. Seventeen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $244.84.

Key Stories Impacting Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported second-quarter EPS of $6.12, well above consensus, and revenue of $5.63 billion, also topping estimates, signaling stronger-than-expected operating performance. Article Title
• Positive Sentiment: The company raised FY 2026 guidance to EPS of $20.30-$21.69, above Wall Street expectations, which suggests management sees continued earnings strength ahead. Article Title
• Positive Sentiment: Investor optimism was also supported by Tenet’s improving credit profile and recent analyst sentiment, which had already set up the stock for a strong move into earnings. Article Title
• Neutral Sentiment: Analysts continue to view the stock favorably overall, with a consensus “Moderate Buy” rating, though some recent commentary has been more cautious on valuation. Article Title

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.